NFE2L2 and Cognitive impairment: Altered expression of Nrf2-targeted genes is associated with AD, and previous studies have demonstrated that the activation of Nrf2 ameliorates Aβ pathology and cognitive deficits in AD mouse models (Bahn et al., 2019).